Position in NTRA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$149,568
-$63,714 QoQ
Shares Held
551
-40.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#672
of 844 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bayforest Capital Ltd holds $1,686,743 across 12 Diagnostics & Research names. NTRA ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
721 | $361,480 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
1,570 | $356,060 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
595 | $315,106 | |
| 4 | LH |
Labcorp Holdings Inc.
|
585 | $163,800 | |
| 5 | NTRA |
Natera, Inc.
This page
|
551 | $149,568 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
223 | $117,396 | |
| 7 | A |
Agilent Technologies, Inc.
|
832 | $110,514 | |
| 8 | VCYT |
Veracyte, Inc.
|
725 | $42,579 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,568 | 551 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $213,282 | 931 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $432,848 | 2,689 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $516,449 | 3,057 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $373,746 | 2,643 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $214,179 | 1,353 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||